{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:36:39Z","timestamp":1784338599851,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"DOI":"10.1038\/s41435-025-00329-3","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:31:34Z","timestamp":1746534694000},"page":"222-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel modulation of T effector memory cells-expressing CD45RA by prednisone in inoperable advanced type B thymoma patients"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6339-6114","authenticated-orcid":false,"given":"Xin-tao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-5035","authenticated-orcid":false,"given":"Jian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-4843","authenticated-orcid":false,"given":"Xing-guo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-9154","authenticated-orcid":false,"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2442-7423","authenticated-orcid":false,"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"329_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jtho.2022.10.016","volume":"18","author":"CB Falkson","year":"2023","unstructured":"Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a systematic review. J Thorac Oncol. 2023;18:299\u2013312.","journal-title":"J Thorac Oncol"},{"key":"329_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamaneurol.2014.4740","volume":"72","author":"DP Richman","year":"2015","unstructured":"Richman DP. The Future of Research in Myasthenia. JAMA Neurol. 2015;72:812\u20134.","journal-title":"JAMA Neurol"},{"key":"329_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","volume":"4","author":"N Girard","year":"2009","unstructured":"Girard N, Mornex F, Van Houtte P, Cordier JF, van Schil P. Thymoma: a focus on current therapeutic management[J]. J Thorac Oncol. 2009;4:119\u201326.","journal-title":"J Thorac Oncol"},{"key":"329_CR4","doi-asserted-by":"crossref","unstructured":"Du X, Cui J, Yu XT, Yu L. Risk factor analysis of thymoma resection and its value in guiding clinical treatment[J]. Cancer Med. 2023;12:13408\u201314.","DOI":"10.1002\/cam4.6043"},{"key":"329_CR5","doi-asserted-by":"publisher","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","volume":"6","author":"N Girard","year":"2011","unstructured":"Girard N, Lal R, Wakelee H, Riely GJ, Loehrer PJ. Chemotherapy definitions and policies for thymic malignancies[J]. J Thorac Oncol. 2011;6:S1749\u201355.","journal-title":"J Thorac Oncol"},{"key":"329_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","volume":"76","author":"K Kondo","year":"2003","unstructured":"Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan[J]. Ann Thorac Surg. 2003;76:878\u201384.","journal-title":"Ann Thorac Surg"},{"key":"329_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1658-3876(09)50022-2","volume":"2","author":"M Hassan","year":"2009","unstructured":"Hassan M, Seoud DE. Multimodality treatments in locally advanced stage thymomas[J]. Hematol Oncol Stem Cell Ther. 2009;2:340\u20134.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"329_CR8","doi-asserted-by":"publisher","first-page":"S323","DOI":"10.1097\/JTO.0b013e3181f20e90","volume":"5","author":"GJ Riely","year":"2010","unstructured":"Riely GJ, Huang J. Induction therapy for locally advanced thymoma[J]. J Thorac Oncol. 2010;5:S323\u20136.","journal-title":"J Thorac Oncol"},{"key":"329_CR9","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","volume":"37","author":"J Cho","year":"2019","unstructured":"Cho J, Kim HS, Ku BM, Choi YL, Cristescu R, Han J, et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II Trial[J]. J Clin Oncol. 2019;37:2162\u201370.","journal-title":"J Clin Oncol"},{"key":"329_CR10","doi-asserted-by":"publisher","first-page":"S286","DOI":"10.1097\/JTO.0b013e3181f209a8","volume":"5","author":"P Strobel","year":"2010","unstructured":"Strobel P, Hohenberger P, Marx A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy[J]. J Thorac Oncol. 2010;5:S286\u201390.","journal-title":"J Thorac Oncol"},{"key":"329_CR11","doi-asserted-by":"crossref","unstructured":"Kalfeist L, Galland L, Ledys F, Ghiringhelli F, Limagne E, Ladoire S. Impact of glucocorticoid use in oncology in the immunotherapy era. Cells. 2022;11:770.","DOI":"10.3390\/cells11050770"},{"key":"329_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.746304","volume":"11","author":"XT Yu","year":"2021","unstructured":"Yu XT, Yu L, Du X, Yu Z, Yang XG, Jiang YX. Clinical and genetic characteristics of thymoma patients with autoimmune hepatitis and myocarditis. Front Oncol. 2021;11:746304.","journal-title":"Front Oncol"},{"key":"329_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.13206","volume":"316","author":"P Laphanuwat","year":"2023","unstructured":"Laphanuwat P, Gomes D, Akbar AN. Senescent T cells: Beneficial and detrimental roles. Immunol Rev. 2023;316:160\u201375.","journal-title":"Immunol Rev"},{"key":"329_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41590-020-0643-3","volume":"21","author":"BI Pereira","year":"2020","unstructured":"Pereira BI, De Maeyer RPH, Covre LP, Belaid DN, Lanna A, Ward S, et al. Sestrins induce natural killer function in senescent-like CD8+ T cells. Nat Immunol. 2020;21:684\u201394.","journal-title":"Nat Immunol"},{"key":"329_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0047-6374(00)00198-6","volume":"121","author":"AN Akbar","year":"2000","unstructured":"Akbar AN, Soares MV, Plunkett FJ, Salmon M. Differential regulation of CD8+ T cell senescence in mice and men. Mech Ageing Dev. 2000;121:69\u201376.","journal-title":"Mech Ageing Dev"},{"key":"329_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exger.2013.11.010","volume":"54","author":"G Pawelec","year":"2014","unstructured":"Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp Gerontol. 2014;54:1\u20135.","journal-title":"Exp Gerontol"},{"key":"329_CR17","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1111\/1759-7714.14157","volume":"12","author":"R Chang","year":"2021","unstructured":"Chang R, Duan S, Li S, Zhang P. Viral infection in thymoma and thymic tumors with autoimmune diseases. Thorac Cancer. 2021;12:2971\u201380.","journal-title":"Thorac Cancer"},{"key":"329_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18697-x","volume":"11","author":"S Gao","year":"2020","unstructured":"Gao S, Jiang JH, Jin C, Gao J, Xiong D, Yang PJ, et al. Interleukin-8 as a candidate for thymoma identification and recurrence surveillance. Nat Commun. 2020;11:4881.","journal-title":"Nat Commun"},{"key":"329_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/284555a0","volume":"284","author":"AH Wyllie","year":"1980","unstructured":"Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555\u20136.","journal-title":"Nature"},{"key":"329_CR20","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4049\/jimmunol.132.4.1761","volume":"132","author":"AH Cohen","year":"1984","unstructured":"Cohen AH, Bluestein HG, Redelman D. Dexyadenosine modulates human suppressor T cell function and B cell differentiation stimulated by Staphylococcus aureus protein A. J Immunol. 1984;132:1761\u20136.","journal-title":"J Immunol"},{"key":"329_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/intimm\/14.5.463","volume":"14","author":"T Berki","year":"2002","unstructured":"Berki T, Palinkas L, Boldizsar F, Nemeth P. Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. Int Immunol. 2002;14:463\u20139.","journal-title":"Int Immunol"},{"key":"329_CR22","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I","volume":"31","author":"GJ Wiegers","year":"2001","unstructured":"Wiegers GJ, Knoflach M, Bock G, Niederegger H, Dietrich H, Falus A, et al. CD4(+)CD8(+) TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol. 2001;31:2293\u2013301.","journal-title":"Eur J Immunol"},{"key":"329_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13607","volume":"21","author":"A Salumets","year":"2022","unstructured":"Salumets A, Tserel L, Rumm AP, Turk L, Kingo K, Saks K, et al. Epigenetic quantification of immunosenescent CD8(+) TEMRA cells in human blood. Aging Cell. 2022;21:e13607.","journal-title":"Aging Cell"},{"key":"329_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577:399\u2013404.","journal-title":"Nature"},{"key":"329_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.121.056730","volume":"146","author":"H Zhu","year":"2022","unstructured":"Zhu H, Galdos FX, Lee D, Waliany S, Huang YV, Ryan J, et al. Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation. 2022;146:316\u201335.","journal-title":"Circulation"},{"key":"329_CR26","first-page":"AB109","volume":"7","author":"Y Wu","year":"2015","unstructured":"Wu Y, Das A, Hayday A, Lal R, Gibbons D. Does IL8 (CXCL8) have a role in thymoma progression and as a marker for relapse?. J Thorac Dis. 2015;7:AB109.","journal-title":"J Thorac Dis"},{"key":"329_CR27","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41591-020-0856-x","volume":"26","author":"KA Schalper","year":"2020","unstructured":"Schalper KA, Carleton M, Zhou M, Chen T, Feng Y, Huang SP, et al. Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors. Nat Med. 2020;26:688\u201392.","journal-title":"Nat Med"},{"key":"329_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/cells11010120","volume":"11","author":"A Filimon","year":"2021","unstructured":"Filimon A, Preda IA, Boloca AF, Negroiu G. Interleukin-8 in melanoma pathogenesis, prognosis and therapy-an integrated view into other neoplasms and chemokine networks. Cells. 2021;11:120.","journal-title":"Cells"},{"key":"329_CR29","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7:1543\u201388.","journal-title":"Theranostics"},{"key":"329_CR30","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/bjc.2015.154","volume":"112","author":"SK Srivastava","year":"2015","unstructured":"Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh AP, Carter JE, et al. Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. Br J Cancer. 2015;112:1772\u201381.","journal-title":"Br J Cancer"},{"key":"329_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1378\/chest.65.1.114","volume":"65","author":"JD Green","year":"1974","unstructured":"Green JD, Forman WH. Response of thymoma to steroids[J]. Chest. 1974;65:114\u20136.","journal-title":"Chest"},{"key":"329_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ana.410020511","volume":"2","author":"JB Posner","year":"1977","unstructured":"Posner JB, Howieson J, Cvitkovic E. Disappearing\u201d spinal cord compression: oncolytic effect of glucocorticoids (and other chemotherapeutic agents) on epidural metastases[J]. Ann Neurol. 1977;2:409\u201313.","journal-title":"Ann Neurol"},{"key":"329_CR33","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s13760-021-01731-0","volume":"122","author":"V Zouvelou","year":"2022","unstructured":"Zouvelou V, Vamvakaris I, Tentolouris-Piperas V, Potaris K, Velonakis G. The effect of glucocorticoids on radiology and histology of thymoma in myasthenia gravis[J]. Acta Neurol Belg. 2022;122:1073\u20135.","journal-title":"Acta Neurol Belg"},{"key":"329_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s004280000333","volume":"438","author":"H Tateyama","year":"2001","unstructured":"Tateyama H, Takahashi E, Saito Y, Fukai I, Fujii Y, Niwa H, et al. Histopathologic changes of thymoma preoperatively treated with corticosteroids[J]. Virchows Arch. 2001;438:238\u201347.","journal-title":"Virchows Arch"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00329-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00329-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00329-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:54:54Z","timestamp":1750085694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-025-00329-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1038\/s41435-025-00329-3","relation":{},"ISSN":["1476-5470"],"issn-type":[{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all participants who signed consent forms for this study. The study was approved by the Human Research Ethics Board of Beijing Tongren Hospital, Capital Medical University, and all experiments were performed following relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}